Use of immunotoxins in the treatment of lymphoma.
Sausville
E A
EA
Developmental Therapeutics Program, National Cancer Institute, Rockville, Maryland, USA.
D000818:Animals; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D008223:Lymphoma / Q000188:drug therapy*; D051379:Mice; D008954:Models, Biological; D011500:Protein Synthesis Inhibitors / Q000627:therapeutic use*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000627:therapeutic use; D012276:Ricin / Q000627:therapeutic use
D000922:Immunotoxins; D011500:Protein Synthesis Inhibitors; D019253:Proto-Oncogene Proteins c-bcl-2; D012276:Ricin